Page 61 - Škrgat, Sabina, ed. 2023. Severe Asthma Forum - Monitoring and Treatable Traits in Severe Asthma. Koper: University of Primorska Press. Severe Asthma Forum, 2
P. 61
protected brush specimen. Am J Med. 37. Azim A, Newell C, Barber C, et al. Cli- 61
1988 Oct;85(4):499-506. nical evaluation of type 2 disease status
28. Taube C, Holz O, Mücke M, et al. Air- in a real-world population of difficult induced sputum role in severe asthma phenotyping
way response to inhaled hypertonic sa- to manage asthma using historic ele-
line in patients with moderate to severe ctronic healthcare records of blood eo-
chronic obstructive pulmonary disease. sinophil counts. Clin Exp Allergy. 2021
Am J Respir Crit Care Med. 2001 Nov Jun;51(6):811-820.
15;164(10 Pt 1):1810-5.
29. Wong HH, Fahy JV. Safety of one 38. Barber C, Azim A, Newell C, et al. Va-
method of sputum induction in asth- lidation and further insight into the In-
matic subjects. Am J Respir Crit Care ternational Severe Asthma Registry
Med. 1997 Jul;156(1):299-303. (ISAR) eosinophil gradient algorithm
30. de la Fuente PT, Romagnoli M, et al. in the Wessex AsThma CoHort of dif-
Safety of inducing sputum in patients ficult asthma (WATCH) using histori-
with asthma of varying severity. Am J cal blood eosinophil counts and indu-
Respir Crit Care Med. 1998 Apr;157(4 ced sputum. Clin Exp Allergy. 2022
Pt 1):1127-30. Jun;52(6):792-6.
31. Kelly MG, Brown V, Martin SL, et al.
Comparison of sputum induction us-
ing high-output and low-output ul-
trasonic nebulizers in normal subjects
and patients with COPD. Chest. 2002
Sep;122(3):955-9.
32. Khan SY, O’Driscoll BR. Is nebu-
lized saline a placebo in COPD? BMC
Pulm Med. 2004 Sep 30:4:9. doi:
10.1186/1471-2466-4-9.
33. Tiotiu A, Badi Y, Kermani NZ, et
al. Association of Differential Mast
Cell Activation with Granulocytic In-
flammation in Severe Asthma. Am
J Respir Crit Care Med. 2022 Feb
15;205(4):397-411.
34. Fricker M, Qin L, Sánchez-Ovando
S, et al. An altered sputum macropha-
ge transcriptome contributes to the ne-
utrophilic asthma endotype. Allergy.
2022 Apr;77(4):1204-15.
35. Vlachos-Mazer H, Leigh R, Sharon RF,
et al. Success and safety of sputum in-
duction in the clinical setting. Eur Res-
pir J. 2000 Nov;16(5):997-1000.
36. Pavord ID, Pizzichini MM, Pizzichini
E, et al. The use of induced sputum to
investigate airway inflammation. Tho-
rax. 1997 Jun;52(6):498-501.
1988 Oct;85(4):499-506. nical evaluation of type 2 disease status
28. Taube C, Holz O, Mücke M, et al. Air- in a real-world population of difficult induced sputum role in severe asthma phenotyping
way response to inhaled hypertonic sa- to manage asthma using historic ele-
line in patients with moderate to severe ctronic healthcare records of blood eo-
chronic obstructive pulmonary disease. sinophil counts. Clin Exp Allergy. 2021
Am J Respir Crit Care Med. 2001 Nov Jun;51(6):811-820.
15;164(10 Pt 1):1810-5.
29. Wong HH, Fahy JV. Safety of one 38. Barber C, Azim A, Newell C, et al. Va-
method of sputum induction in asth- lidation and further insight into the In-
matic subjects. Am J Respir Crit Care ternational Severe Asthma Registry
Med. 1997 Jul;156(1):299-303. (ISAR) eosinophil gradient algorithm
30. de la Fuente PT, Romagnoli M, et al. in the Wessex AsThma CoHort of dif-
Safety of inducing sputum in patients ficult asthma (WATCH) using histori-
with asthma of varying severity. Am J cal blood eosinophil counts and indu-
Respir Crit Care Med. 1998 Apr;157(4 ced sputum. Clin Exp Allergy. 2022
Pt 1):1127-30. Jun;52(6):792-6.
31. Kelly MG, Brown V, Martin SL, et al.
Comparison of sputum induction us-
ing high-output and low-output ul-
trasonic nebulizers in normal subjects
and patients with COPD. Chest. 2002
Sep;122(3):955-9.
32. Khan SY, O’Driscoll BR. Is nebu-
lized saline a placebo in COPD? BMC
Pulm Med. 2004 Sep 30:4:9. doi:
10.1186/1471-2466-4-9.
33. Tiotiu A, Badi Y, Kermani NZ, et
al. Association of Differential Mast
Cell Activation with Granulocytic In-
flammation in Severe Asthma. Am
J Respir Crit Care Med. 2022 Feb
15;205(4):397-411.
34. Fricker M, Qin L, Sánchez-Ovando
S, et al. An altered sputum macropha-
ge transcriptome contributes to the ne-
utrophilic asthma endotype. Allergy.
2022 Apr;77(4):1204-15.
35. Vlachos-Mazer H, Leigh R, Sharon RF,
et al. Success and safety of sputum in-
duction in the clinical setting. Eur Res-
pir J. 2000 Nov;16(5):997-1000.
36. Pavord ID, Pizzichini MM, Pizzichini
E, et al. The use of induced sputum to
investigate airway inflammation. Tho-
rax. 1997 Jun;52(6):498-501.
